Drug Discovery World

APRIL 3, 2023

DS: What motivated you and Dr David Bunka, CTO, to create Aptamer and did you imagine you would one day be operating on such a global scale?    AT : We initially met at the University of Leeds, where David was a post-doctoral researcher studying aptamers, and I was completing my PhD. Optimer binders are engineered to overcome these problems.

Science 130

Science Molecular Biology Therapies Small Molecule 130

Elrig

APRIL 29, 2024

Jasmine has a background in neuroscience and genetic manipulation, with early works focused on using a combined structural and molecular biology approach to assess disease-associated proteins implicated in Alzheimer’s disease. big pharma or startups/spin off? Where do you enjoy more to work? What pro/cons?

Bioinformatics 59

Bioinformatics Molecular Biology Drugs Cell Based Assays 59

Drug Discovery World

AUGUST 16, 2022

In recent years, governments, institutes, pharma companies, and funding bodies have taken significant measures to proactively address cancer disparities. However, these social categories are rather arbitrary and don’t necessarily correspond to the underlying molecular biology of the patient, risking misguided clinical care.

Research 130

Research Clinical Trials Trials Drug Development 130

Codon

FEBRUARY 13, 2024

” A Global View Even as advances in computing and molecular biology usher in the era of a new, high-tech “phage therapy 2.0”, Doctors commonly encounter at least 13 or 14 bacterial species with drug-resistant strains across a range of infections in different parts of the body. UTIs, diabetic foot ulcers).

Therapies 138

Therapies DNA Virus Clinical Trials 138